Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.40 (-0.65) | AIM:£3.24 (+0)
上一篇文章   |   下一篇文章
新闻稿, 集团 | 2016-05-04

Chi-Med to Participate in Two Healthcare Investor Conferences in May

London—May 2, 2016—Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announced that Chief Executive Officer Christian Hogg will present a corporate overview at two healthcare investor conferences in May.

Conference Details:

Event: Deutsche Bank 41st Annual Health Care Conference
Date/Time: Thursday, May 5, 2016 at 10:40 a.m. EDT
Location: Boston, MA

Event: Bank of America Merrill Lynch 2016 Health Care Conference
Date/Time: Thursday, May 12, 2016 at 8:00 a.m. PDT
Location: Las Vegas, NV

A live audio webcast for the Bank of America conference will be available in the Events, Circulars & Forms section of the Company’s website ( A replay of the webcast will also be available following the event.

About Chi-Med

Chi-Med is a China-based, globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001). For more information, please visit:



Investor Inquiries


Christian Hogg, CEO

+852 2121 8200

International Media Inquiries


Anthony Carlisle, Citigate Dewe Rogerson

+44 7973 611 888 (Mobile)

U.S. Media Inquiries


Brad Miles, BMC Communications

+1 (917) 570 7340 (Mobile)

Susan Duffy, BMC Communications

+1 (917) 499 8887 (Mobile)

Investor Relations


Jillian Connell, The Trout Group

+1 (646) 378 2956

David Dible, Citigate Dewe Rogerson

+44 20 7638 9571
+44 7967 566 919 (Mobile)

Panmure Gordon (UK) Limited


Richard Gray / Andrew Potts

+44 (20) 7886 2500